| Primary |
| Ill-defined Disorder |
63.6% |
| Cataract |
9.1% |
| Diabetic Neuropathy |
9.1% |
| Neuralgia |
9.1% |
| Pain In Extremity |
9.1% |
|
| Local Swelling |
33.3% |
| Pain In Extremity |
33.3% |
| Unevaluable Event |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
31.2% |
| Pain |
8.7% |
| Hypertension |
8.0% |
| Neuropathy Peripheral |
6.5% |
| Depression |
5.8% |
| Type 2 Diabetes Mellitus |
5.1% |
| Back Pain |
4.3% |
| Fibromyalgia |
4.3% |
| Neuralgia |
4.3% |
| Plasma Cell Myeloma |
2.9% |
| Arthritis |
2.2% |
| Blood Pressure Abnormal |
2.2% |
| Chronic Paroxysmal Hemicrania |
2.2% |
| Hiv Infection |
2.2% |
| Ischaemic Stroke |
2.2% |
| Pruritus |
2.2% |
| Hypertension |
1.4% |
| Diabetes Mellitus |
1.4% |
| Diabetic Neuropathy |
1.4% |
| Myalgia |
1.4% |
|
| Tremor |
15.2% |
| Drug Interaction |
6.1% |
| Hepatocellular Injury |
6.1% |
| Leukocytoclastic Vasculitis |
6.1% |
| Pneumonia |
6.1% |
| Somnolence |
6.1% |
| Unevaluable Event |
6.1% |
| Urinary Tract Infection |
6.1% |
| Vision Blurred |
6.1% |
| Weight Increased |
6.1% |
| Cardiac Failure |
3.0% |
| Decreased Appetite |
3.0% |
| Diabetes Mellitus |
3.0% |
| Diarrhoea |
3.0% |
| Dizziness |
3.0% |
| Hyponatraemia |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Myocardial Infarction |
3.0% |
| Nausea |
3.0% |
| Nerve Compression |
3.0% |
|
| Concomitant |
| Multiple Sclerosis |
18.4% |
| Plasma Cell Myeloma |
17.9% |
| Product Used For Unknown Indication |
11.7% |
| Drug Use For Unknown Indication |
10.3% |
| Osteoporosis |
9.0% |
| Gait Disturbance |
4.5% |
| Chronic Myeloid Leukaemia |
3.6% |
| Pain |
3.1% |
| Hypertension |
2.7% |
| Relapsing-remitting Multiple Sclerosis |
2.7% |
| Colorectal Cancer |
2.2% |
| Immunodeficiency Common Variable |
1.8% |
| Prostate Cancer |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Systemic Lupus Erythematosus |
1.8% |
| B-cell Lymphoma |
1.3% |
| Diabetes Mellitus |
1.3% |
| Hallucination |
1.3% |
| Multiple Myeloma |
1.3% |
| Spinal Pain |
1.3% |
|
| Vomiting |
13.4% |
| Urinary Tract Infection |
7.3% |
| Weight Decreased |
7.3% |
| Weight Increased |
7.3% |
| Pain |
6.1% |
| Pneumonia |
6.1% |
| Somnolence |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Nausea |
4.9% |
| Diarrhoea |
3.7% |
| Hypertension |
3.7% |
| Plasma Cell Myeloma |
3.7% |
| Pyrexia |
3.7% |
| Rash |
3.7% |
| Urinary Retention |
3.7% |
| Vision Blurred |
3.7% |
| Back Pain |
2.4% |
| Fatigue |
2.4% |
| Full Blood Count Decreased |
2.4% |
| Haemoglobin Decreased |
2.4% |
|
